NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Yan, Sha ^a   Xu, Zhenyao ^a   Lou, Fangzhou ^a   Zhang, Lingyun ^a   Ke, Fang ^a   Bai, Jing ^a   Liu, Zhaoyuan ^a   Liu, Jinlin ^a   Wang, Hong ^a   Zhu, Huiyuan ^a   Sun, Yang ^a   Cai, Wei ^a   Gao, Yuanyuan ^a   Su, Bing ^a   Li, Qun ^a   Yang, Xiao ^b   Yu, Jianxiu ^a   Lai, Yuping ^c   Yu, Xue Zhong ^d   Zheng, Yan ^e   Shen, Nan ^a   Chin, Y Eugene ^a   Wang, Honglin ^a   more..

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^c EAST CHINA NORMAL UNIVERSITY   (China)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 10; FILAGGRIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; LORICRIN; MESSENGER RNA; MICRORNA 31; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 6; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; MICRORNA; MIRN31 MICRORNA, HUMAN; MIRN31 MICRORNA, MOUSE;

DISEASE SEVERITY; GENE EXPRESSION; GENETIC ANALYSIS; IDENTIFICATION METHOD; INHIBITION; PROTEIN; RNA; RODENT; SKIN; SKIN DISORDER;

3' UNTRANSLATED REGION; ACANTHOSIS; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; EPIDERMIS HYPERPLASIA; FEMALE; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PSORIASIS; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SKINFOLD THICKNESS; TRANSCRIPTION INITIATION SITE; UPREGULATION; AGED; ANIMAL; EPIDERMIS; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CYTOKINES; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERPLASIA; KERATINOCYTES; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; MIDDLE AGED; NF-KAPPA B; PHOSPHOPROTEIN PHOSPHATASES; PSORIASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 84936791909     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8652     Document Type: Article

References (45)

1. Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496-509 (2009).
2. Schon, M. P. & Boehncke, W. H. Psoriasis. N. Engl. J. Med. 352, 1899-1912 (2005).
3. Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866-873 (2007).
4. Tsuruta, D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat. Inflamm. Allergy Drug Discov. 3, 40-48 (2009).
5. Beg, A. A. et al. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6, 1899-1913 (1992).
6. Pahl, H. L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866 (1999).
7. Lizzul, P. F. et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J. Invest. Dermatol. 124, 1275-1283 (2005).
8. Moorchung, N. et al. Role of NF-kappaB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Int. J. Dermatol. 53, 570-574 (2014).
9. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41, 199-204 (2009).
10. Sun, L. D. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005-1009 (2010).
11. Stuart, P. E. et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat. Genet. 42, 1000-1004 (2010).
12. Huffmeier, U. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 42, 996-999 (2010).
13. Jordan, C. T. et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am. J. Hum. Genet. 90, 796-808 (2012).
14. Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379 (2010).
15. Ichihara, A. et al. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br. J. Dermatol. 165, 1003-1010 (2011).
16. Joyce, C. E. et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum. Mol. Genet. 20, 4025-4040 (2011).
17. Lerman, G. et al. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS ONE 6, e20916 (2011).
18. Sonkoly, E. et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2, e610 (2007).
19. Xu, N. et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J. Invest. Dermatol. 131, 1521-1529 (2011).
20. Meisgen, F. et al. MiR-21 is up-regulated in psoriasis and suppresses T-cell apoptosis. Exp. Dermatol. 21, 312-314 (2012).
21. Xu, N. et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J. Immunol. 190, 678-688 (2013).
22. Wang, H. et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116, 2105-2114 (2006).
23. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
24. Rizzo, H. L. et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J. Immunol. 186, 1495-1502 (2011).
25. Leonardi, C. et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190-1199 (2012).
26. Papp, K. A. et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366, 1181-1189 (2012).
27. Zhu, S. et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat. Med. 18, 1077-1086 (2012).
28. Wang, L. et al. IL-6 induces NF-kappa B activation in the intestinal epithelia. J. Immunol. 171, 3194-3201 (2003).
29. Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139 (2009).
30. Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443-448 (2012).
31. Grossman, R. M. et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl Acad. Sci. USA 86, 6367-6371 (1989).
32. Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
33. Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B. & Lizzul, P. F. NF-kappaB: an essential transcription factor in psoriasis. J. Dermatol. Sci. 69, 89-94 (2013).
34. Pedrioli, D. M. et al. miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol. Cell Biol. 30, 3620-3634 (2010).
35. Korner, C. et al. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J. Biol. Chem. 288, 8750-8761 (2013).
36. Liu, X. et al. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J. Biol. Chem. 286, 42371-42380 (2011).
37. Peng, H. et al. microRNA-31/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation. Proc. Natl Acad. Sci. USA 109, 14030-14034 (2012).
38. Mardaryev, A. N. et al. Micro-RNA-31 controls hair cycle-associated changes in gene expression programs of the skin and hair follicle. FASEB J. 24, 3869-3881 (2010).
39. Song, J. J. et al. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nat. Struct. Biol. 10, 1026-1032 (2003).
40. Bata-Csorgo, Z., Hammerberg, C., Voorhees, J. J. & Cooper, K. D. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J. Exp. Med. 178, 1271-1281 (1993).
41. Zeng, K., Bastos, R. N., Barr, F. A. & Gruneberg, U. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2. J. Cell Biol. 191, 1315-1332 (2010).
42. Mao, C. M. et al. [Establishment of keratinocyte-specific Cre recombinase transgenic mice]. Yi Chuan Xue Bao 30, 407-413 (2003).
43. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
44. Blackwell, T. S. et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 162, 1095-1101 (2000).
45. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).